Macular Fast Track™️ 2023

Macular Fast Track™️ 2023

Torremolinos, Andalusia, Spain

Hotel Amaragua, Torremolinos, Costa del Sol, Spain

October 23, 2023

Section Page Hero Image


October 23, 2023
Hotel Amaragua, Torremolinos, Costa del Sol, Spain
Pre-meeting to the International Symposium on Retinal Degeneration

View Program

BrightFocus Foundation will hold its second Macular Fast Track workshop to help speed progress towards finding a cure for macular degeneration by investing in promising young scientists in the field of vision research.

Graduate students, postdoctoral fellows, and other early-stage scientists focused on macular degeneration research, or those who want to enter the field can take advantage of this unique opportunity to accelerate their path towards becoming an expert in this exciting field by:

  • immersing themselves in the background knowledge and latest discoveries in macular degeneration research and
  • connecting with preeminent macular degeneration scientists and fellow early-stage researchers in the U.S. and around the world.

Co-organizers and Co-chairs:

  • Preeti Subramanian, PhD
  • John D. Ash, PhD
  • Catherine Bowes Rickman, PhD

Travel Award Applications due June 1, 2023.

Register Here

List of topics and speakers for Macular Fast Track 2023

(On mobile devices, you may need to swipe left to see all of the table columns below.)


A Multilayer Deposit-driven AMD Progression Sequence

Christine A. Curcio, PhD FARVO
University of Alabama at Birmingham School of Medicine

Imaging AMD: Current Efforts and Future Directions

Joseph Carroll, PhD
The Medical College of Wisconsin

Genetics of AMD

Gregory S. Hageman, PhD
University of Utah - John A. Moran Eye Center

Cellular Mechanisms that Drive Vision Loss in AMD

Aparna Lakkaraju, PhD 
University of California, San Francisco

Metabolism and Metabolic Defects in AMD 

Jianhai Du, PhD 
West Virginia University

Regulation of Innate immunity in RPE 

Andrew D. Dick, FMedSci 
Moorfields Eye Hospital and UCL-Institute of Ophthalmology

How Genetic and Environmental AMD Risk Factors Shape Pathogenic Inflammation 

Florian Sennlaub, MD, PhD 
Institut de la Vision 

Wet AMD, Therapy Development

Daniel Martin, MD
Cleveland Clinic